The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Eisai; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; MSD
Research Funding - MSD
Travel, Accommodations, Expenses - Ipsen
Autologous cytotoxic T-cell receptor T cell therapy (SCG101) against hepatitis B surface antigen phase I/II trial for patients with advanced hepatitis B-related hepatocellular carcinoma.
 
Ghassan K. Abou-Alfa
Consulting or Advisory Role - AstraZeneca; Autem Medical; Boehringer Ingelheim (I); Eisai; Exelixis; Helio Health; Incyte; Ipsen; Merck Serono; Newbridge Pharmaceuticals; Novartis (I); QED Therapeutics; Roche/Genentech; SERVIER; Yiviva
Research Funding - Arcus Ventures (Inst); AstraZeneca (Inst); BioNtech (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Helsinn Healthcare (Inst); Puma Biotechnology (Inst); QED Therapeutics (Inst); Yiviva (Inst)
 
Wei-Peng Yong
Consulting or Advisory Role - Abbvie/Genentech; Amgen; AstraZeneca; Bristol-Myers Squibb; Ipsen; Novartis
Speakers' Bureau - Bayer; Eisai; Lilly; MSD Oncology; Sanofi/Aventis; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Pfizer
 
Stephen Lam Chang
No Relationships to Disclose
 
Jia Fan
No Relationships to Disclose
 
Han Chong Toh
Stock and Other Ownership Interests - Tessa Therapeutics
Honoraria - AstraZeneca; Ipsen; Roche; Tessa Therapeutics
Consulting or Advisory Role - Tessa Therapeutics
Speakers' Bureau - AstraZeneca; Eisai; Ipsen; Roche; Tessa Therapeutics
Research Funding - Bristol-Myers Squibb; MSD; Roche
Patents, Royalties, Other Intellectual Property - Neotila
Travel, Accommodations, Expenses - Roche
 
Thomas Yau
Honoraria - AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology
Consulting or Advisory Role - Bristol-Myers Squibb
 
SuPin Choo
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene
Honoraria - AstraZeneca; BMS; Eisai; Ipsen; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; MSD Oncology; Roche; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Taiho Pharmaceutical
 
Jing Wang
Employment - SCG Cell Therapy
Stock and Other Ownership Interests - SCG Cell Therapy
 
Nicole Kusuma
Employment - SCG Cell Therapy
Leadership - SCG Cell Therapy
Stock and Other Ownership Interests - SCG Cell Therapy
 
Christy Ma
Employment - SCG Cell Therapy
Leadership - SCG Cell Therapy
Stock and Other Ownership Interests - SCG Cell Therapy
Travel, Accommodations, Expenses - SCG Cell Therapy
 
Shukui Qin
No Relationships to Disclose